SLN
Silence Therapeutics plc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
13F top-10 QoQ
Top fund weight
—
Silence Therapeutics plc
Expected move
InputsNext report
Last report
—
Largest filed tie
13F top-10 QoQ
Top fund weight
—
19.76
−0.04 · −0.20%
post 19.76 0.00%
Linked news
NewsNo reported quarters.
Bar = avg |move| to ±5% · tick = ±3.5% avg day · ×base = |move| ÷ ±3.5% · min 6 releases
| Quarter | Reported | EPS | Consensus |
|---|---|---|---|
| Q2 FY26 | — | -0.09 | — |
| Q1 FY26 | — | -0.11 | — |
Source: filed financials
Expected move
Inputsspot 19.75exp Nov 20ATM strike 20ATM straddle 0.25IV 3%
No linked exposure.